Research programme: m6A regulating molecules - Race Oncology
Alternative Names: N6-methyladenosine regulating molecules - Race OncologyLatest Information Update: 21 Jul 2023
At a glance
- Originator Race Oncology
- Class Antineoplastics
- Mechanism of Action RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 13 Jul 2023 Early research in Cancer in Australia (unspecified route) (Race Oncology pipeline, July 2023)